SOURCE-LINKED INTELLIGENCE

Cell Factory on chips: make Cell Therapies affordable and accessible to all patients

CORDIS · observation · Publication date unknown

llowed by an integrated end-to-end device will be developed. Finally, we aim to market an autonomous, self-optimising manufacturing system based on real-time manufacturing optimisation via AI driven (artificial intelligence) predictive process control. Our product offer will include (a) desktop instruments, (b) single-use microfluidic cartridges, and (c) software and algorithms. Cell Therapy, integrated photonics, semiconductor

Read original source ↗ Open in workspace

recordType

award

status

CLOSED

region

EU

value

75000

unit

EUR